Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$236M |
| 2 |
CVS Health
CVS
|
+$189M |
| 3 |
Mastercard
MA
|
+$155M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$112M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$814M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$763M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$315M |
| 4 |
SPDR Gold Trust
GLD
|
+$140M |
| 5 |
JD.com
JD
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.96% |
| 2 | Healthcare | 19.03% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Addus HomeCare
ADUS
$2.23B
| $2.09M | 0.01% |
25,098
+2,425
| +11% | +$203K |
|
|
VIVO
677
DELISTED
Meridian Bioscience Inc
VIVO
| $2.08M | 0.01% |
68,427
+6,199
| +10% | +$168K |
|
678
Dover
DOV
$28.4B
| $2.07M | 0.01% |
17,092
-31,179
| -65% | -$4.22M |
|
|
SIX
679
DELISTED
Six Flags Entertainment Corp.
SIX
| $2.07M | 0.01% |
95,409
+90,314
| +1,773% | +$2.88M |
|
|
FRC
680
DELISTED
First Republic Bank
FRC
| $2.05M | 0.01% |
14,213
-4,760
| -25% | -$713K |
|
681
Visteon
VC
$2.78B
| $2.05M | 0.01% |
19,751
+937
| +5% | +$96.7K |
|
682
Envista
NVST
$4.52B
| $2.04M | 0.01% |
52,965
-180,552
| -77% | -$7.59M |
|
|
AVNS
683
DELISTED
Avanos Medical
AVNS
| $2.03M | 0.01% |
74,209
+6,640
| +10% | +$191K |
|
684
Essential Utilities
WTRG
$11.4B
| $2M | 0.01% |
43,560
+12,636
| +41% | +$587K |
|
685
TransDigm Group
TDG
$67.7B
| $1.99M | 0.01% |
3,698
+626
| +20% | +$369K |
|
686
Keysight
KEYS
$58.3B
| $1.98M | 0.01% |
14,391
-92,156
| -86% | -$13.1M |
|
|
SILK
687
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.96M | 0.01% |
53,950
+8,332
| +18% | +$303K |
|
688
Adient
ADNT
$1.5B
| $1.96M | 0.01% |
66,124
-2,272
| -3% | -$76.3K |
|
|
CVGW
689
DELISTED
Calavo Growers
CVGW
| $1.94M | 0.01% |
46,427
+2,392
| +5% | +$86.6K |
|
690
Darling Ingredients
DAR
$9.44B
| $1.92M | 0.01% |
32,044
+2,734
| +9% | +$208K |
|
691
Newell Brands
NWL
$2.56B
| $1.92M | 0.01% |
+100,585
| New | +$2.14M |
|
692
Astrana Health
ASTH
$1.77B
| $1.91M | 0.01% |
49,602
+6,454
| +15% | +$245K |
|
693
AdaptHealth
AHCO
$759M
| $1.91M | 0.01% |
105,837
+9,051
| +9% | +$147K |
|
694
ScottsMiracle-Gro
SMG
$3.66B
| $1.88M | 0.01% |
23,853
+11,531
| +94% | +$1.14M |
|
695
SL Green Realty
SLG
$3.99B
| $1.86M | 0.01% |
40,408
+1,187
| +3% | +$75.5K |
|
696
Ametek
AME
$58.2B
| $1.85M | 0.01% |
16,865
-56,382
| -77% | -$6.85M |
|
|
FITB
697
Fifth Third Bancorp
FITB
$51.8B
| $1.85M | 0.01% |
54,971
-20,062
| -27% | -$754K |
|
698
Novavax
NVAX
$1.31B
| $1.82M | 0.01% |
35,356
+31,335
| +779% | +$1.62M |
|
699
BioNTech
BNTX
$23.5B
| $1.81M | 0.01% |
+12,156
| New | +$1.86M |
|
700
Gen Digital
GEN
$17.5B
| $1.8M | 0.01% |
82,003
-42,012
| -34% | -$1.03M |
|
Similar funds
Ray Dalio's Q2 2022 Portfolio in Review
As of Q2 2022, Ray Dalio held 1,084 positions worth $23.6B, down 4.9% from $24.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ray Dalio deployed $1.38B of net new capital in Q2 2022, opening 116 new positions and adding to 613 existing holdings. Its largest new stake was Sea Limited: 459,240 shares worth $30.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $763M trimmed.
- Ray Dalio's largest Q2 2022 buy was Sea Limited: 459,240 shares worth $30.7M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $236M increase.
- Ray Dalio's biggest Q2 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $763M.
- Ray Dalio fully exited Alibaba in Q2 2022, selling an estimated $814M.
- Ray Dalio's ten largest holdings make up 29% of its $23.6B portfolio in Q2 2022.
- Ray Dalio opened 116 new positions and closed 99 in Q2 2022.
- Ray Dalio's portfolio value fell 4.9% quarter-over-quarter to $23.6B.
Based on Bridgewater Associates's 13F filing for Q2 2022, filed 11 Aug 2022.